Does ICOTINIB Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with ICOTINIB. This represents 24.4% of all adverse event reports for ICOTINIB.
10
Reports of Malignant neoplasm progression with ICOTINIB
24.4%
of all ICOTINIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ICOTINIB?
Of the 10 reports, 2 (20.0%) resulted in death, 2 (20.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICOTINIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ICOTINIB Cause?
Rash (14)
Hypertension (12)
Diarrhoea (10)
Fatigue (9)
Bone marrow failure (7)
Proteinuria (7)
Vomiting (7)
Disease progression (6)
Haemorrhage (6)
Nausea (6)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)